Diane Wara, MD

Diane Wara, MD

Allergy & Immunology San Francisco, CA

Recalled Faculty/Academic Specialist, Pediatrics, UCSF School of Medicine


Office Address

  • 400 Parnassus Ave
    San Francisco, CA 94143
    Phone: (415) 476-2491
    Fax: (415) 502-7540

Diane Wara, MD

Allergy & Immunology San Francisco, CA

Recalled Faculty/Academic Specialist, Pediatrics, UCSF School of Medicine

Clinical Specialties & Interests

  • Allergy & Immunology: General Allergy & Immunology

Education & Training

  • UCSFUCSF
  • Harbor - UCLA Medical CenterHarbor - UCLA Medical Center
  • University of California Irvine School of MedicineUniversity of California Irvine School of Medicine

Certifications & Licensure

  • CA State Medical LicenseCA State Medical License1970 - 2016
  • American Board of PediatricsPediatrics
  • American Board of Allergy and ImmunologyAllergy & Immunology

    Awards, Honors, & Recognition

    • Elected MemberInstitute of Medicine, 1998
    • Super DoctorSuperDoctors.com

    Clinical Trials

    Publications & Presentations

    PubMed

    Grant Support

    • Effects Of Haart On The Recovery Of Immune Function In Hiv-Infected ChildrenNational Center For Research Resources
      2005 - 2005
    • Pactg 1020-A, Version 20National Center For Research Resources
      2005 - 2005
    • Pediatric LATE Outcomes Protocol (Aids Clinical Trials Group: 219c)National Center For Research Resources
      2005 - 2005
    • Pactg P1057: Phase I/II Randomized Trial Of Cold Adapted Influenza VaccineNational Center For Research Resources
      2005 - 2005
    • Pactg P1045: Morphologic And Metabolic Abnormalities In Children &YouthNational Center For Research Resources
      2005 - 2005
    • Pactg P1042s: Cognitive, Behavioral And Psychosocial CorrelatesNational Center For Research Resources
      2005 - 2005
    • Pactg P1025: Perinatal Core Protocol For Data From Hiv-Infected Pregnant WomenNational Center For Research Resources
      2004 - 2005
    • Pactg P1026s:Pharmacokinetic Properties Of Antiretroviral Drugs During PregnancyNational Center For Research Resources
      2004 - 2005
    • Pactg P1030: Phase I/II Study Of Lopinavir/Ritonavir In HIV-1 Infected InfantsNational Center For Research Resources
      2004 - 2005
    • Pactg 1020-A, Version 2.0National Center For Research Resources
      2004 - 2004
    • Phase I/II Study Of Alvac HIV Vaccine In ChildrenNational Center For Research Resources
      2004 - 2005
    • Immunological And Neurodevelopmental Consequences Of Chromosome 22q11.2 DeletionNational Center For Research Resources
      2004 - 2004
    • Defective T- And B- Cell Signaling In Patients With Inherited ImmunodeficienciesNational Center For Research Resources
      2004 - 2005
    • Clinical And Molecular Investigation Of Primary ImmunodeficienciesNational Center For Research Resources
      2004 - 2005
    • Phase I/II Trial Of Subcutaneous IL-2 With Antiretroviral Therapy In HIVNational Center For Research Resources
      2004 - 2004
    • Pediatric LATE Outcomes Protocol (Actg 219c)National Center For Research Resources
      2004 - 2004
    • Pactg P1021: Emtricitabine With Efavirenz And Didanosine In A Once Daily RegimenNational Center For Research Resources
      2004 - 2004
    • Pactg P1024: Evaluation Of Pneumococcal Vaccine In Hiv-Infected ChildrenNational Center For Research Resources
      2004 - 2005
    • Northern California Pediatrics AIDS Treatment CenterNational Institute Of Allergy And Infectious Diseases
      2002 - 2006
    • ACTG 351: CD4 Igg2 In HIV Infected ChildrenNational Center For Research Resources
      2000 - 2002
    • ACTG 366: Antiretroviral Algorithm For Children Of 4 Drug CombinationNational Center For Research Resources
      2000 - 2002
    • Quantifying HIV 1 RNA In CSF &Blood Of HIV Infected ChildrenNational Center For Research Resources
      2000 - 2002
    • ACTG 395: Indinavir W/ Stavudine &Lamivudine For Pediatric HIV 1 InfNational Center For Research Resources
      2000 - 2002
    • Opportunistic Infection Events In HIV Infected ChildrenNational Center For Research Resources
      2000 - 2000
    • Correlation Of Growth With HIV Viral Load In ChildrenNational Center For Research Resources
      2000 - 2000
    • Saquinavir Combination Therapy For HIV ChildrenNational Center For Research Resources
      2000 - 2000
    • ACTG 377: Pram 2 Comparing 4 Antiretroviral RegimensNational Center For Research Resources
      2000 - 2002
    • ACTG 316: Nevirapine VS Placebo For Preventing Maternal Fetal TransmissionNational Center For Research Resources
      1999 - 2002
    • Actg250--Safety/Pks Of Nevirapine In HIV1 Infected Pregnant Women/NeonatesNational Center For Research Resources
      1998 - 1999
    • Impact Of Diagnostic Disclosure On HIV Infected ChildrenNational Center For Research Resources
      1998 - 2002
    • Nevirapine VS Placebo To Prevent Maternal-Fetal HIV TransmissionNational Center For Research Resources
      1998 - 2002
    • Safety And Immunogenicity Of Recombinant HIV 1National Center For Research Resources
      1998 - 1999
    • Phase II Rolling Arm Master Protocol Of Novel Antiretroviral Therapy In HIVNational Center For Research Resources
      1998 - 2002
    • Phase I/II Trial Of Recombinant IL 2 In Symptomatic HIV Infected ChildrenNational Center For Research Resources
      1998 - 2002
    • Atovaquone In HIV Infected Infants And ChildrenNational Center For Research Resources
      1998 - 2002
    • Atovaquone And AZT Versus Tmp In HIV Infected ChildrenNational Center For Research Resources
      1998 - 2002
    • Phase I/II Study Of Hivig In Slowing Progress Of Disease In HIV Infected ChildNational Center For Research Resources
      1997 - 1999
    • Hyperimmune Anti HIV Immunoglobulin For Preventing Maternal/Fetal TransmissionNational Center For Research Resources
      1997 - 1999
    • Atovaquone And AZT Versus Tmp In HIV Infected ChildrenNational Center For Research Resources
      1997 - 1997
    • Single Dose PK And Safety Of Oral Adefovir Dipivoxil In HIV Infected ChildrenNational Center For Research Resources
      1997 - 1999
    • Phase I Evaluation Of Safety/Toxicity Of ZDV And DDI Combination TherapyNational Center For Research Resources
      1997 - 2002
    • Safety/Pharmacokinetics Of Nevirapine In HIV Infected Pregnant Women/NeonatesNational Center For Research Resources
      1996 - 1996
    • Trial Of DDC In Treatment Of Children With Symptomatic HIV InfectionNational Center For Research Resources
      1996 - 1996
    • Actg--Pediatric HIV LATE Outcomes ProtocolNational Center For Research Resources
      1996 - 1996
    • Hyperimmune Anti-Hiv Immunoglobulin For Preventing Maternal/Fetal TransmissionNational Center For Research Resources
      1996 - 1996
    • Combined Zdv-Lamivudine VS DDI VS Zdv-Ddi In HIVNational Center For Research Resources
      1996 - 1999
    • Atovaquone &Azt Vs. Tmp In HIV Infected ChildrenNational Center For Research Resources
      1996 - 1996
    • Pk, Safety, Tolerance And Activity Of Ddc/Zdv In Pediatric Patients With HIVNational Center For Research Resources
      1996 - 1996
    • Combination Antiretroviral Therapy In Children And Adolescents With Advanced HIVNational Center For Research Resources
      1995 - 1999
    • Phase I Safety And PK Study Of Atovaquone In HIV Infected Infants And ChildrenNational Center For Research Resources
      1995 - 1997
    • Treating SCID Due To ADA Deficiency With CD34+ Selected Autologous Stem CellsNational Center For Research Resources
      1995 - 2002
    • Randomized Comparative Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources
      1995 - 1997
    • Pediatric HIV LATE Outcomes ProtocolNational Center For Research Resources
      1995 - 2002
    • Clinical Investigation Of The Patient With Primary Immunodeficiency DisorderNational Center For Research Resources
      1995 - 2002
    • AZT VS DDI VS Azt/Ddi Combination In Symptomatic HIV Infected ChildrenNational Center For Research Resources
      1995 - 1999
    • High VS Low Dose Of DDI In Children With Symptomatic HIV InfectionNational Center For Research Resources
      1995 - 1995
    • Three New HIV Vaccines In HIV Infected ChildrenNational Center For Research Resources
      1995 - 1999
    • HIV-1 Infected Pediatric Slow Or Rapid ProgressorsNational Center For Research Resources
      1995 - 1995
    • Phase II Study To Evaluate Pk, Safety, Tolerance And Activity Of DDCNational Center For Research Resources
      1995 - 1995
    • Phase I Study--Safety And Immungenicity Of HIV-1 Recombinant Envelope AntigenNational Center For Research Resources
      1995 - 1995
    • Phase II Trial Of DDC In Treatment Of Children With Symptomatic HIV InfectionNational Center For Research Resources
      1995 - 1995
    • BAY Area Perinatal AIDS Cohort StudyEunice Kennedy Shriver National Institute Of Child Health &Human Development
      1992 - 1993
    • Northern California Pediatric AIDS Treatment CenterNational Institute Of Allergy And Infectious Diseases
      1988 - 2001
    • Immunological Sciences Study SectionCenter For Scientific Review
      1987 - 1989
    • Safety Tolerance And OPEN Efficiency Of Rhcg Immune Serum GlobulinNational Center For Research Resources
      1985 - 1985
    • Effects Of Thymosin On The Immune Function In ChildrenNational Center For Research Resources
      1985 - 1985

    Hospital Affiliations

    • The full profile is locked and available to verified physicians only.
      Join over 60% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Wara's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV